Setting 
My Cart
Toggle Nav
Close
  • Menu
  • Setting

Signaling Pathways

Signal transduction pathways constitute a precisely regulated network through which cells perceive external stimuli and initiate intracellular responses. Core research in this field focuses on the mechanisms of molecular signal transmission and regulation within cells and typically encompasses three fundamental stages: signal initiation, signal propagation through cascades, and downstream effector responses. Key molecules—including proteins, nucleic acids, and small molecules—interact with high specificity and are subject to tight regulation (e.g., protein phosphorylation, molecular activation/inhibition). These processes underpin the full spectrum of cellular activities, including proliferation, differentiation, metabolism, apoptosis, and immune responses. While accurate regulation of these pathways is essential for maintaining organismal homeostasis, their dysregulation is a major driver of the onset and progression of diseases such as cancer, neurodegenerative disorders, and autoimmune diseases.


APExBIO is strongly committed to advancing life science research by providing a comprehensive portfolio of small-molecule tools designed to support the elucidation of signaling mechanisms and the identification of key regulatory targets—critical steps for deciphering disease etiology and developing innovative therapies. Our offerings span all major signal transduction pathways, including classical pathways (e.g., PI3K/Akt, MAPK, NF-κB), emerging modalities (e.g., ferroptosis, cuproptosis, pyroptosis), and research on pathway crosstalk. With tens of thousands of products—including inhibitors, activators, and modulators—we robustly support research in oncology, immunology, neuroscience, epigenetics, and other key fields.


Every APExBIO product undergoes rigorous functional validation and purity testing, ensuring suitability for diverse research applications such as pathway mechanism studies, target identification and validation, drug activity evaluation, cell-based assays, and animal model development. We complement our high-quality tools with comprehensive support: each product is supplied with detailed chemical property reports, biological activity data, standardized usage guidelines, and extensive literature citations in high-impact journals. In addition, we provide end-to-end assistance—from product selection and experimental protocol optimization to technical troubleshooting—enabling researchers to rely on tool quality, focus on core scientific questions, and accelerate progress in signal transduction research and translational medicine.

Items 2591-2600 of 10830

Page
per page
  1. McMMAF
    BA2627 McMMAF
    Summary: McMMAF is composed of the highly efficient microtubule inhibitor MonomethylF (MMAF) coupled with the protecting group maleimidocaproyl, which can be used as the active molecular linker.
  2. SMCC-DM1
    BA2628 SMCC-DM1
    Summary: SMCC-DM1 (DM1-SMCC) is formed by linking the linkerSMCC to the toxic molecule DM1 and can be used to prepare antibody-coupled active molecules.
  3. MC-VA-PAB-Exatecan
    BA2633 MC-VA-PAB-Exatecan
    Summary: MC-VA-PAB-Exatecan is part of an antibody-coupled active molecule.
  4. Mal-PEG8-Val-Ala-PAB-Exatecan
    BA2636 Mal-PEG8-Val-Ala-PAB-Exatecan
    Summary: Mal-PEG8-Val-Ala-PAB-Exatecan is an antibody-active molecule coupling linker.
  5. DM21
    BA2643 DM21
    Summary: DM21 is a cleavable affix of an ADC active molecule and linker (ADClinker).
  6. MC-SN38
    BA2651 MC-SN38
    Summary: MC-SN38 is an active molecular coupler consisting of SN38, a potent microtubule disruptor, and a non-cleavable MClinker for the synthesis of antibody active molecular couplers (ADCs).
  7. Mal-PEG2-Gly-Gly-Phe-Gly-Exatecan
    BA2667 Mal-PEG2-Gly-Gly-Phe-Gly-Exatecan
    Summary: Mal-PEG2-Gly-Gly-Phe-Gly-Exatecan is an ADC.
  8. GGFG-amide-glycol-amide-Exatecan
    BA2681 GGFG-amide-glycol-amide-Exatecan
    Summary: GGFG-amide-glycol-amide-Exatecan (Intermediate2) is a derivative.
  9. MC-Gly-Gly-Phe-Gly-Cyclobutanecarboxylic-Exatecan
    BA2688 MC-Gly-Gly-Phe-Gly-Cyclobutanecarboxylic-Exatecan
    Summary: MC-Gly-Gly-Phe-Gly-Cyclobutanecarboxylic-Exatecan is part of an antibody-coupled active molecule consisting of (MC-Gly-Gly-Phe-Gly-Cyclobutanecarboxylic) coupled to a DNA topoisomerase I inhibitor.
  10. MC-Gly-Gly-Phe-Gly-GABA-Exatecan
    BA2707 MC-Gly-Gly-Phe-Gly-GABA-Exatecan
    Summary: MC-Gly-Gly-Phe-Gly-GABA-ExatecanADC is a drug-linker coupler containing 22 μM topoisomerase.

Items 2591-2600 of 10830

Page
per page